Created with Sketch.
Primary Care Update
33 minutes | Oct 17, 2021
Episode 88: influenza, stroke prevention, a novel telemedicine use, and T2DM overtreatment
Join Kate, Henry, John and Mark as they discuss antivirals in children hospitalized with influenza, DAPT for secondary stroke prevention, the safety and effectiveness of no-test medical abortions, and harms of overtreating older persons with T2DM.
25 minutes | Sep 30, 2021
Episode 87: COVID boosters, ivermectin, and pregnancy outcomes with COVID infection
Kate, Mark, John and Henry discuss the value of three doses of mRNA vaccine for immunocompromised people, Ivermectin for treating persons with COVID-19, the benefits of boosters based on Israeli data, and pregnancy outcomes of women with COVID-19 infection.
30 minutes | Sep 15, 2021
Episode 86: dexamethasone post-op, topical terbinafine for toenails, thromboprophylaxis, and vaccine adverse events
This week Kate, Mark, Henry and John (he's back!) discuss dexamethasone after major non-cardiac surgery, topical terbinafine for onychomycosis, thromboprophylaxis during knee replacement, and mRNA COVID vaccine adverse events
30 minutes | Sep 3, 2021
Episode 85: aspirin and antidepressant doses, how low to go with BP, and eye drops for migraine
This week, Kate, Henry and Mark discuss comparative efficacy of aspirin doses, blood pressure lowering and health outcomes, dosing of antidepressants, timolol eye drops for acute migraine treatment
28 minutes | Aug 19, 2021
Episode 84: adenotonsillectomy in kids with OSA, DAPT vs ASA for stroke prevention, and ovarian cancer screening
This week Kate, Henry and Mark give John the week off and discuss outcomes after adenotonsillectomy in children with OSA, the effectiveness and safety of DAPT vs ASA for secondary stroke prevention, and the final results of the largest trial of screening for ovarian cancer using CA-125 and ultrasound.
29 minutes | Aug 3, 2021
Episode 83: TIA risk score, US for frractures, CDC delta variant report, and harms of MRI
This week, Kate, Henry, Mark and John will discuss the Canadian TIA score, ultrasound for diagnosing upper extremity fractures in children, a summary of the leaked CDC report on breakthrough cases and the delta variant, and how MRI reports can cause harm
25 minutes | Jul 22, 2021
Episode 82: PCR stool tests in kids, duration of antibiotics for CAP in kids, and an UGI bleed guideline
This week, we give John the episode off, so Kate, Mark and Henry will discuss rapid stool tests in children with community acquired diarrhea, a guideline for managing patients with acute UGI bleeding, and the best duration of antibiotics for ambulatory kids with community-acquired pneumonia
32 minutes | Jul 8, 2021
Episode 81: LDL targets, guided antiplatelet therapy, CRC screening, and myocarditis after mRNA vax
This week, we will discuss LDL targets after stroke, guided antiplatelet therapy after PCI, updated CRC screening recommendation from the USPSTF, and the risk of myocarditis after mRNA-based COVID vaccination. For CME credit go to IAFP.com and click on the online education link, and then find our podcast.
30 minutes | Jun 24, 2021
Episode 80: Cannabis, PRP for plantar fasciitis, epidural steroids, and COVID mortality and race
This week, Kate, Mark, John and henry will discuss cannabis use in patients with rheumatologic disorders, platelet-rich plasma injections for persons with plantar fasciitis, epidural steroid injections for sciatica, and COVID mortality and race.
28 minutes | Jun 11, 2021
Episode 79: caffeine in pregnancy, DM and cancer, ruling out MI, and COVID reinfection
This week we tackle caffeine in pregnancy, new onset diabetes and cancer risk; a clinical prediction tool to help rule out acute myocardial infarction and a report on the frequency of COVID reinfection.
27 minutes | May 27, 2021
Episode 78: PCN allergy, US guided injections, IBS, and prediabetes prognosis
This week, Kate, Mark, Henry and John will discuss penicillin allergy, US-guided steroid injections, psychological therapies for patients with IBS and the natural history of “prediabetes”. Plus the quiz from Kate.
27 minutes | May 13, 2021
Episode 77: deprescribing antibiotics, BP screening recommendations, vit D and fish oil to prevent AF, and steroids for wheeze preschoolers.
This week, Kate, Mark, John and Henry discuss a proven strategy to decrease antibiotic prescribing, learn about updated USPSTF recommendations for blood pressure screening, whether vitamin D and fish oil for prevent A fib, and the value of oral steroids for wheezy preschoolers age 2 to 5.
24 minutes | Apr 29, 2021
Episode 76: inhaled steroids work for early COVID, new opiate rules, managing metatarsal fracture, and mRNA vaccines in pregnancy
We are really excited to introduce our new co-host, Dr. Kate Rowland, an Associate Professor in the Department of Family Medicine at Rush University in Chicago. We have been teaching with Kate for a long time in our in-person courses, and it's great to have her on board for the podcast. This week we talk about a new study from Oxford University finding a clear benefit for inhaled steroids in patients newly diagnosed with COVID-19. Kate discusses changes (good ones!) in regulations around MAT, Henry has good news about managing 5th metatarsal fractures, and John closes with data on the safety of mRNA vaccines in pregnancy. And the quiz!
26 minutes | Apr 15, 2021
Episode 75: Duration of symptoms with mild and severe COVID, and true rate of vaccine anaphylaxis
This week, Mark reports the first study looking at the duration of symptoms with mild COVID in healthcare workers (more than you think) compared to those without COVID. Then Henry looks at the same thing in hospitalized COVID patients compared to those with other respiratory infections in the US and UK, and John tells us the true rate of anaphylaxis with vaccines.
27 minutes | Apr 2, 2021
Episode 74: More flozins and tides, Lyme disease, and something new for acute migraine
This week we discuss a huge and really important meta-analysis of SGLT-2 inhibitors (flozins) and GLP-1 agonists (tides). Also, a good guideline on Lyme disease diagnosis and treatment, and a novel approach to treating migraine.
23 minutes | Mar 20, 2021
Episode 73: low-carb diets for T2DM, chronic back pain, and reinfection with COVID
This week: low-carb diets for patients with T2DM, managing patients with chronic back pain, and reinfection rates in patients with COVID. Plus the quiz, and a reality TV recommendation.
27 minutes | Mar 4, 2021
Episode 72: Flozins and tides, new med for migraine, and antidepressants for back pain and DJD
This week, Mark, Henry and guest POET Kate Rowland from Rush Medical College discuss: newer agents to treat diabetes, a new medication for migraine prevention, and antidepressants for pain in patients with back pain or DJD.
26 minutes | Feb 18, 2021
Episode 71: thromboprophylaxis for COVID inpatients, colchicine for outpatients with COVID, and COVID variant mortality
This week, we will discuss a potpourri of COVID studies: a large propensity score matched study of thromboprophylaxis in hospitalized patients, novel use of colchicine for COVID-19, and mortality associated with mutant SARS-CoV-2 strains.
29 minutes | Feb 6, 2021
Episode 70: colchicine for heart disease, pregnancy after contraception, and prostate CA screening
This week, we will discuss: a novel use for an old-time drug, pregnancy after contraception, and prostate cancer screening.
30 minutes | Jan 22, 2021
Episode 69: baricitinib + remdesivir, positive study of convalescent plasma, and long-haulers
Today, and all COVID episode. Does adding baricitinib improve outcomes in patients on remdesivir; convalescent plasma given early in high risk elders; and how common are long-hauler symptoms.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021